Association of rs62063857 Variant of the Saitohin Gene with Parkinson’s Disease
- 259 Downloads
Saitohin gene found within the tau gene is thought to play a role in the pathogenesis of neurodegenerative diseases. The rs62063857 polymorphism originally found in the saitohin gene seems to be the responsible SNP in this event. This polymorphism is studied mostly in patients with Alzheimer’s disease. Data on Parkinson’s disease are scarce. Therefore, we examined the rs62063857 polymorphism in 583 Parkinson’s disease patients (347 male and 236 female) and 396 healthy controls (238 male and 158 female) by a polymerase chain reaction and restriction fragment length polymorphism method to see whether it was associated with Parkinson’s disease from the City of Istanbul, Turkey. The G allele frequency was 22 % in overall controls and 16 % in Parkinson’s disease patients. In this study, the saitohin rs62063857 polymorphism was associated with Parkinson’s disease (χ2 = 16.765; P = 0.000). Individuals with the AA genotype showed 1.7-fold increased risk for Parkinson’s disease (χ2 = 16.680; P = 0.000), whereas individuals with the AG genotype revealed protection against Parkinson’s disease (χ2 = 14.554; P = 0.000). After the stratification analysis according to gender, both male and female PD patients showed association with the alleles and genotypes of the rs62063857 polymorphism of the saitohin gene (χ2 = 9.476, P = 0.009; χ2 = 7.593, P = 0.022, respectively). When the Parkinson’s patients were divided into two groups with regard to onset of the disease, both groups showed association with the disease. The Parkinson’s patients with disease onset below 65 years of age showed 1.8-fold increased risk for the disease. The Parkinson’s patients with disease onset over 65 showed more robust association with a 2.051-fold increased risk for the disease. Consequently, the rs62063857 polymorphism of the saitohin gene is a genetic risk factor for Parkinson’s disease. Hence, this polymorphism may play a role in the etiology of Parkinson’s disease.
KeywordsParkinson’s disease Saitohin gene Q7R polymorphism rs62063857 Association Disease onset Neurodegenerative disease Turkey
The study presented herein is done using the departmental resources.
Conflicts of interest
The authors declare that they have no conflicts of interest. They also declare that all authors were fully involved in the study and preparation of the manuscript.
- Johansson A, Zetterberg H, Håkansson A, Nissbrandt H, Blennow K (2005) TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer’s disease and are not associated with frontotemporal dementia or Parkinson’s disease. Neurodegener Dis 2(1):28–35PubMedCrossRefGoogle Scholar
- Pepłońska B, Zekanowski C, Religa D, Czyzewski K, Styczyńska M, Pfeffer A, Gabryelewicz T, Gołebiowski M, Luczywek E, Wasiak B, Barczak A, Chodakowska M, Barcikowska M, Kuźnicki J (2003) Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population. Neurosci Lett 348(3):163–166PubMedCrossRefGoogle Scholar
- Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S, Pezzoli G, Singer C, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Laramie JM, DeStefano AL, Litvan I, Nicholson G, Corbett A, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Sherman S, Al-hinti J, Drasby E, Nance M, Moller AT, Ostergaard K, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH (2008) Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology 71(1):28–34PubMedCentralPubMedCrossRefGoogle Scholar
- Verpillat P, Ricard S, Hannequin D, Dubois B, Bou J, Camuzat A, Pradier L, Frebourg T, Brice A, Clerget-Darpoux F, Deleuze JF, Campion D, French Study Group on Alzheimer’s Disease and Frontotemporal Dementia (2002) Is the saitohin gene involved in neurodegenerative diseases? Ann Neurol 52(6):829–832PubMedCrossRefGoogle Scholar
- Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H (2007) Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson’s disease. Ann Neurol 62(2):137–144PubMedCentralPubMedCrossRefGoogle Scholar